Therapeutic nanotechnologies for Alzheimer's disease: A critical analysis of recent trends and findings.

Delbreil, Philippe; Rabanel, Jean-Michel; Banquy, Xavier; Brambilla, Davide

Delbreil, Philippe; Rabanel, Jean-Michel; Banquy, Xavier; Brambilla, Davide.

Affiliation

Delbreil P; Faculté de Pharmacie, Université de Montréal, 2940 Chemin de Polytechnique, Montréal, Québec H3T 1J4, Canada.
Rabanel JM; Faculté de Pharmacie, Université de Montréal, 2940 Chemin de Polytechnique, Montréal, Québec H3T 1J4, Canada.
Banquy X; Faculté de Pharmacie, Université de Montréal, 2940 Chemin de Polytechnique, Montréal, Québec H3T 1J4, Canada.
Brambilla D; Faculté de Pharmacie, Université de Montréal, 2940 Chemin de Polytechnique, Montréal, Québec H3T 1J4, Canada. Electronic address: davide.brambilla@umontreal.ca.

Adv Drug Deliv Rev ; 187: 114397, 2022 08.

Article in En | MEDLINE | ID: mdl-35738546

Subject(s)

Alzheimer Disease; Neurodegenerative Diseases; Alzheimer Disease/drug therapy; Drug Delivery Systems; Humans; Nanomedicine; Nanotechnology; Neurodegenerative Diseases/drug therapy

Key words

Alzheimer's disease; Amyloid beta; Biodistribution; Clinical; Gene editing; Gene therapy; Lipid; Liposomes; Nanomedicine; Nanoparticles; Nanotechnology; Oxidative stress; Pharmacodynamics; Pharmacokinetics; Polymeric; Preclinical; Tau

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Neurodegenerative Diseases / Alzheimer Disease Type of study: Diagnostic_studies / Prognostic_studies Limits: Humans Language: En Journal: Adv Drug Deliv Rev Journal subject: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2022 Type: Article Affiliation country: Canada

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google